We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis to Help Produce Roche’s Actemra as COVID-19 Treatment
Novartis to Help Produce Roche’s Actemra as COVID-19 Treatment
Novartis has agreed to help manufacture Roche’s blockbuster rheumatoid arthritis drug Actemra (tocilizumab) as a COVID-19 treatment — in another pact that offers the company’s manufacturing might to help produce a rival’s COVID-19 therapies or vaccines.